PMC:7029759 / 26717-27004 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"624","span":{"begin":104,"end":108},"obj":"Gene"},{"id":"632","span":{"begin":151,"end":160},"obj":"Species"},{"id":"633","span":{"begin":161,"end":169},"obj":"Species"},{"id":"652","span":{"begin":49,"end":53},"obj":"Disease"},{"id":"653","span":{"begin":143,"end":147},"obj":"Disease"},{"id":"673","span":{"begin":264,"end":268},"obj":"Gene"},{"id":"683","span":{"begin":196,"end":205},"obj":"Species"},{"id":"684","span":{"begin":206,"end":214},"obj":"Species"}],"attributes":[{"id":"A624","pred":"tao:has_database_id","subj":"624","obj":"Gene:59272"},{"id":"A632","pred":"tao:has_database_id","subj":"632","obj":"Tax:2697049"},{"id":"A633","pred":"tao:has_database_id","subj":"633","obj":"Tax:9606"},{"id":"A652","pred":"tao:has_database_id","subj":"652","obj":"MESH:D012128"},{"id":"A653","pred":"tao:has_database_id","subj":"653","obj":"MESH:D012128"},{"id":"A673","pred":"tao:has_database_id","subj":"673","obj":"Gene:59272"},{"id":"A683","pred":"tao:has_database_id","subj":"683","obj":"Tax:2697049"},{"id":"A684","pred":"tao:has_database_id","subj":"684","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ation has the same clinical benefits in treating ARDS that have been seen in animal models, and whether ACE2-Fc administration could alleviate ARDS in 2019-nCoV patients.\nThe proposed therapy for 2019-nCoV patients would consist of the extracellular domain of the ACE2 protein fused to a"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T549","span":{"begin":77,"end":83},"obj":"NCBITaxon:33208"},{"id":"T548","span":{"begin":104,"end":108},"obj":"G_3;PG_10;PR:000003622"},{"id":"T547","span":{"begin":151,"end":160},"obj":"SP_7"},{"id":"T546","span":{"begin":196,"end":205},"obj":"SP_7"},{"id":"T545","span":{"begin":236,"end":249},"obj":"GO:0005576"},{"id":"T544","span":{"begin":250,"end":256},"obj":"SO:0000417"},{"id":"T543","span":{"begin":264,"end":268},"obj":"G_3;PG_10;PR:000003622"}],"text":"ation has the same clinical benefits in treating ARDS that have been seen in animal models, and whether ACE2-Fc administration could alleviate ARDS in 2019-nCoV patients.\nThe proposed therapy for 2019-nCoV patients would consist of the extracellular domain of the ACE2 protein fused to a"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T160","span":{"begin":269,"end":276},"obj":"Body_part"}],"attributes":[{"id":"A160","pred":"fma_id","subj":"T160","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"ation has the same clinical benefits in treating ARDS that have been seen in animal models, and whether ACE2-Fc administration could alleviate ARDS in 2019-nCoV patients.\nThe proposed therapy for 2019-nCoV patients would consist of the extracellular domain of the ACE2 protein fused to a"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T98","span":{"begin":49,"end":53},"obj":"Disease"},{"id":"T99","span":{"begin":143,"end":147},"obj":"Disease"}],"attributes":[{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A99","pred":"mondo_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"ation has the same clinical benefits in treating ARDS that have been seen in animal models, and whether ACE2-Fc administration could alleviate ARDS in 2019-nCoV patients.\nThe proposed therapy for 2019-nCoV patients would consist of the extracellular domain of the ACE2 protein fused to a"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T245","span":{"begin":6,"end":9},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T246","span":{"begin":77,"end":83},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_33208"},{"id":"T247","span":{"begin":109,"end":111},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T248","span":{"begin":286,"end":287},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ation has the same clinical benefits in treating ARDS that have been seen in animal models, and whether ACE2-Fc administration could alleviate ARDS in 2019-nCoV patients.\nThe proposed therapy for 2019-nCoV patients would consist of the extracellular domain of the ACE2 protein fused to a"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T110","span":{"begin":269,"end":276},"obj":"Chemical"}],"attributes":[{"id":"A110","pred":"chebi_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"ation has the same clinical benefits in treating ARDS that have been seen in animal models, and whether ACE2-Fc administration could alleviate ARDS in 2019-nCoV patients.\nThe proposed therapy for 2019-nCoV patients would consist of the extracellular domain of the ACE2 protein fused to a"}